Radiobiology of radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin). [electronic resource]
Producer: 20040204Description: 6-10 p. digitalISSN:- 0093-7754
- Antibodies, Monoclonal -- pharmacology
- Antigens, CD20
- Antigens, Neoplasm
- Apoptosis -- radiation effects
- Cell Cycle -- radiation effects
- Dose-Response Relationship, Radiation
- Humans
- Lymphoma, B-Cell -- immunology
- Lymphoma, Non-Hodgkin -- immunology
- Radioimmunotherapy -- methods
- Yttrium Radioisotopes -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.